Jefferies Financial Group

Selected news for the capital firm - Jefferies Financial Group, collected since 4/2019. Recent stories appear in Dakota Financial News and com-unik.info. This capital firm shares healthcare news with Medical Research, GlaxoSmithKline, Fresenius Medical Care, GSK, Amarin and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/22/2021 Tenet Healthcare's (THC) Buy Rating Reiterated at Jefferies Financial Group - Mayfield Recorder Mayfield Recorder Tenet Healthcare’s (THC) Buy Rating Reiterated at Jefferies Financial Group Posted by Denise Davis on Jun 22nd, 2021 Share on StocktwitsJefferies Financial Group reissued their buy rating on shares of Tenet Healthcare (NYSE:THC) in a research note issued to investors on Friday morning, PriceTargets.com reports.A number of other research analysts have also weighed in on the company. Mizuho upped their price objective on Tenet Healthcare from ...
6/13/2021 Brokers Offer Predictions for Mesa Laboratories, Inc.'s Q1 2023 Earnings (NASDAQ:MLAB) - Transcript Daily transcriptdaily.com Mesa Laboratories, Inc. (NASDAQ:MLAB) – Stock analysts at Jefferies Financial Group issued their Q1 2023 earnings estimates for shares of Mesa Laboratories in a report issued on Wednesday, June 9th. Jefferies Financial Group analyst B. Couillard anticipates that the medical instruments supplier will post earnings of $0.65 per share for the quarter. Jefferies Financial Group also issued estimates for Mesa Laboratories’ Q2 2023 earnings at $0.65 EPS, Q3 ...
6/9/2021 Community Health Systems (NYSE:CYH) Reaches New 12-Month High at $16.50 baseballnewssource.com ... stock traded as high as $16.50 and last traded at $16.47, with a volume of 2420 shares traded. The stock had previously closed at $16.10.CYH has been the topic of several research reports. Jefferies Financial Group raised shares of Community Health Systems from a “hold” rating to a “buy” rating and increased their price target for the stock from $11.00 to $18.00 in a research report on ...
6/9/2021 The Goldman Sachs Group Reiterates “CHF 432” Price Target for Rogers (VTX:ROG) slatersentinel.com ... report on Tuesday, March 9th. JPMorgan Chase & Co. set a CHF 310 price target on shares of Rogers and gave the stock a “neutral” rating in a research report on Tuesday, May 25th. Jefferies Financial Group set a CHF 330 price target on shares of Rogers and gave the stock a “neutral” rating in a research report on Wednesday, April 21st. Sanford C. Bernstein set a CHF 360 ...
6/9/2021 Deutsche Bank Aktiengesellschaft Reaffirms “Buy” Rating for AstraZeneca (LON:AZN) slatersentinel.com ... target on the biopharmaceutical company’s stock.A number of other brokerages have also commented on AZN. Citigroup reissued a buy rating on shares of AstraZeneca in a research note on Wednesday, February 24th. Jefferies Financial Group set a GBX 8,850 ($115.63) target price on AstraZeneca and gave the company a buy rating in a research report on Friday, June 4th. Barclays restated an overweight rating on shares of AstraZeneca ...
6/9/2021 Zacks Investment Research Downgrades Akero Therapeutics (NASDAQ:AKRO) to Hold - Transcript Daily transcriptdaily.com ... treatment of non-alcoholic steatohepatitis, which are in clinical stage. Akero Therapeutics Inc. is based in San Francisco, United States. “Get Akero Therapeutics alerts: AKRO has been the topic of several other reports. Jefferies Financial Group restated a buy rating and set a $48.00 target price on shares of Akero Therapeutics in a report on Tuesday, March 23rd. HC Wainwright raised their price objective on Akero Therapeutics from $61.00 ...
6/9/2021 Stock Traders Purchase Large Volume of Call Options on Biogen (NASDAQ:BIIB) zolmax.com ... Stock traders acquired 111,622 call options on the stock. This is an increase of 1,410% compared to the average volume of 7,392 call options.BIIB has been the topic of several recent research reports. Jefferies Financial Group raised their target price on shares of Biogen from $450.00 to $500.00 and gave the stock a “buy” rating in a report on Tuesday. Raymond James raised shares of Biogen from an ...
6/9/2021 AstraZeneca (LON:AZN) Given a GBX 9,000 Price Target by Credit Suisse Group Analysts - Ticker Report Ticker Report ... a buy rating in a report on Monday. Berenberg Bank reiterated a buy rating and set a GBX 9,500 ($124.12) price target on shares of AstraZeneca in a research note on Tuesday, May 11th. Jefferies Financial Group set a GBX 8,850 ($115.63) price objective on shares of AstraZeneca and gave the company a buy rating in a research note on Friday, June 4th. Finally, Liberum Capital restated a buy rating ...
5/29/2021 Q3 2021 EPS Estimates for Agilent Technologies, Inc. Raised by Jefferies Financial Group (NYSE:A) - Ticker Report Ticker Report Agilent Technologies, Inc. (NYSE:A) – Investment analysts at Jefferies Financial Group upped their Q3 2021 earnings per share estimates for shares of Agilent Technologies in a report released on Wednesday, May 26th. Jefferies Financial Group analyst B. Couillard now forecasts that the medical research company will post earnings of $0.98 per share for the quarter, up from their previous estimate of $0.90. Jefferies Financial Group also issued estimates for ...
5/18/2021 1Life Healthcare (NASDAQ:ONEM) Price Target Lowered to $50.00 at Credit Suisse Group - Ticker Report Ticker Report ... a report on Monday, March 8th. Canaccord Genuity reduced their price target on 1Life Healthcare from $64.00 to $56.00 and set a buy rating for the company in a report on Thursday, May 13th. Jefferies Financial Group assumed coverage on shares of 1Life Healthcare in a research report on Monday, May 10th. They set a buy rating and a $63.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft raised ...
5/18/2021 1Life Healthcare (NASDAQ:ONEM) Stock Price Up 7.9% dispatchtribunal.com ... hands during mid-day trading, a decline of 99% from the average daily volume of 1,313,041 shares. The stock had previously closed at $32.98.Several equities analysts have recently issued reports on ONEM shares. Jefferies Financial Group initiated coverage on shares of 1Life Healthcare in a report on Monday, May 10th. They set a “buy” rating and a $63.00 target price for the company. Evercore ISI started coverage on ...
5/15/2021 Jefferies Financial Group Comments on Healthcare Trust of America, Inc.'s Q3 2021 Earnings (NYSE:HTA) baseballnewssource.com Jefferies Financial Group Comments on Healthcare Trust of America, Inc.’s Q3 2021 Earnings (NYSE:HTA) Posted by Don MillerHealthcare Trust of America, Inc. (NYSE:HTA) – Equities researchers at Jefferies Financial Group decreased their Q3 2021 earnings per share estimates for shares of Healthcare Trust of America in a report released on Wednesday, May 12th. Jefferies Financial Group analyst J. Petersen now expects that the real estate investment ...
5/12/2021 ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Up 4.6% After Analyst Upgrade zolmax.com ... had previously closed at $20.84.Other research analysts also recently issued reports about the stock. Mizuho restated a “hold” rating on shares of ACADIA Pharmaceuticals in a research report on Thursday, May 6th. Jefferies Financial Group reiterated a “hold” rating and issued a $21.00 price objective (down previously from $40.00) on shares of ACADIA Pharmaceuticals in a research report on Tuesday, April 13th. Royal Bank of Canada decreased ...
5/12/2021 Jefferies Financial Group Weighs in on Vanda Pharmaceuticals Inc.'s Q2 2021 Earnings (NASDAQ:VNDA) The Markets Daily Jefferies Financial Group Weighs in on Vanda Pharmaceuticals Inc.’s Q2 2021 Earnings (NASDAQ:VNDA) Posted by Danessa Lincoln on May 12th, 2021 // Comments offVanda Pharmaceuticals Inc. (NASDAQ:VNDA) – Research analysts at Jefferies Financial Group increased their Q2 2021 EPS estimates for Vanda Pharmaceuticals in a note issued to investors on Wednesday, May 5th. Jefferies Financial Group analyst C. Howerton now anticipates that the biopharmaceutical company will earn ...